Even though greater part of U.S.-based cannabis businesses and lots of foreign American Depository Receipts (ADRs) trade within the countertop (OTC), a marijuana that is few are exchanged in the NASDAQ. Some investors choose shares which are listed on the NASDAQ to many other exchanges for their increased liquidity and tighter spreads set alongside the markets that are over-the-counter. For instance, while the cannabis industry has exploded in present months and years, uplisting from an OTC market to an established U.S. change is now a banner achievement for several marijuana that is rising. (For related reading, see “Understanding healthcare Cannabis vs. Recreational Cannabis shares”)
An number that is increasing of businesses are increasingly being noted on reputable U.S. exchanges instead of being traded from the OTC market showing the fast development of the cannabis industry.
NASDAQ-listed Marijuana shares
The NASDAQ had been initial electronic trade and has long been synonymous with technology and biotechnology. The cannabis businesses regarding the NASDAQ mirror this, additionally the greater part of them run into the biotech area of the industry. Here you will find the marijuana that is NASDAQ-listed, in alphabetical purchase, at the time of October 26, 2019, with a failure of these total returns.
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)
Arena Pharmaceuticals is really a biotech business active in the manufacturing of medical marijuana drugs. Research and development around Arena’s APD371 may be the main focus of this company’s cannabis biotech initiatives.
Atlantic Alliance Partnership Corp. (NASDAQ:AAPC)
Atlantic Alliance Partnership Corp. is a blank check company that is currently in a merger contract with Kalyx developing Inc. Kalyx is a number one investment rely upon the regulated cannabis industry in america.
Key Takeaways
- The cannabis industry, especially the part of cannabis and biotech, is attracting investor attention that is substantial.
- Cannabis will be utilized in brand brand new drugs to treat discomfort and numerous chronic, inflammatory, and fibrotic diseases.
- Organizations may also be developing cannabinoid services and products for autism range disorders, schizophrenia, glioma, Tourette problem, epileptic disorders, Prader-Willi Syndrome (a genetic disorder), and addiction that is amphetamine.
Cara Therapeutics Inc. (NASDAQ:CARA)
Cara Therapeutics is just a clinical-stage biotechnology business focused on developing and commercializing chemical that is new when it comes to indications of discomfort and pruritus (itching). Although most of the company’s clinical-stage services and products target opioid receptors, Cara is conducting research that is preclinical cannabinoids to treat neuropathic discomfort.
Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP)
Corbus Pharmaceuticals Holdings Inc. is a cannabis biotech company. The team’s research, development, and manufacturing are based around cannabis medications that look for to treat chronic, inflammatory, fibrotic, along with other conditions.
Cronos Group Inc. (NASDAQ:CRON)
Cronos Group Inc. is A canadian cannabis company. The group has and seeks cannabis-related subsidiaries and producers that are licensed. In December of 2018, Marlboro manufacturer Altria announced intends to spend $1.8 billion in Cronos. The investment has provided Cronos not just with extra money to invest in its continued expansion but additionally by having a well-established partner experienced into the advertising of consumer brands.
Greenlane Holdings Inc. (NASDAQ:GNLN)
Greenlane Holdings Inc. is just a Boca Raton, Florida-based cannabis business. It distributes many different cannabis usage accessories and vaporization gear and items to customers that are retail the U.S. and Canada. Also, it runs websites that are e-commerce extra sales.
GW Pharmaceuticals Plc. (NASDAQ:GWPH)
GW Pharmaceuticals is creating a profile of cannabinoid medications. These medications consist of Sativex for the treating spasticity linked to sclerosis that is multiple cancer pain and Epidiolex to treat youth epilepsy. Sativex is commercialized much more compared to a dozen nations away from united states of america and has now gotten regulatory approval in some other countries. Epidiolex received Food And Drug Administration approval as a treatment for Dravet Syndrome and Lennox-Gastaut Syndrome, two types of serious, very early what is cbd oil beginning epilepsy without good existing treatments. Other indications reveal that GW Pharmaceuticals is developing cannabinoid services and products for autism range disorders, schizophrenia, and glioma.
Intec Pharma Ltd. (NASDAQ:NTEC)
Intec Pharma is really a clinical-stage biopharmaceutical business that is developing medications considering its proprietary Accordion Pill technology. Intec’s item pipeline includes cannabinoid-based medications for lower pain that is back fibromyalgia.
Marrone Bio Innovations, Inc. (NASDAQ:MBII)
Marrone Bio Innovations, Inc. develops and distributes environmentally accountable bio-based pest administration and plant wellness services and products. In 2017, Marrone Bio Innovations announced that three MBII ingredients that are active now legal to be used on cannabis plants when you look at the Ca cultivation market.
Modern Age Beverages Corp. (NASDAQ:NBEV)
Modern age Beverages Corp. is just a maker of beverages produced from yerba mate, green tea extract, kombucha, and comparable items. In current months, New Age has expanded its drink offerings to add CBD infusions too, bringing it in to the orbit of cannabis shares.
OrganiGram Holdings Inc. (NASDAQ:OGI)
Canadian cannabis producer OrganiGram Holdings Inc. debuted from the NASDAQ in might of 2019, rendering it probably the most current cannabis businesses to record regarding the exchange that is popular. The organization is quickly expanding its manufacturing ability and could have the ability to create up to 113,000 kilograms of item per by the end of 2019 year.
Psychemedics Corporation (NASDAQ:PMD)
Psychemedics Corporation operates into the enforcement sector. The company’s business operations support drug assessment through hair examples.
Sundial Growers Inc. (NASDAQ:SNDL)
Alberta, Canada-based Sundial Growers Inc. is yet another brand new entry on the NASDAQ trade. The cannabis producer made headlines in October of 2019 (and saw a price that is brief) whenever it announced the production of a unique Palmetto model of leisure cannabis, first for sale in Saskatchewan and Manitoba.
Therapix Biosciences Ltd. (NASDAQ:TRPX)
Therapix Biosciences Ltd. is just a specialty clinical-stage pharmaceutical company concentrated from the growth of cannabinoid-based medications. Therapix’s present pipeline includes services and products targeted to treat Tourette problem and mild intellectual impairment.
Tilray Inc. (NASDAQ:TLRY)
Tilray Inc. had been the very first company that is marijuana-related have a preliminary public providing (IPO) in the us. The Nanaimo, Vancouver Island-based company concentrates on medical cannabis services and products.
Village Farms Global (NASDAQ:VFF)
Village Farms Overseas is considered the most cannabis that are recent to begin investing on the NASDAQ. The business’s stocks became readily available for trade on 21, 2019 february. The business includes a decades-long history in greenhouse produce manufacturing and contains just recently shifted some of its focus toward cannabis manufacturing.
Zynerba Pharmaceuticals Inc. (NASDAQ:ZYNE)
Zynerba Pharmaceuticals is focused from the growth of synthetic cannabinoid remedies for transdermal (through skin) distribution. Their pipeline presently includes two drugs being developed for indications epilepsy that is including osteoarthritis, fibromyalgia, peripheral neuropathic discomfort, and delicate X syndrome.